Medical research

Detailed picture of how myoV 'walks' along actin tracks

A new study in the Journal of General Physiology uses state-of-the-art fluorescence microscopy to provide a striking 3-D picture of how class V myosins (myoV) "walk" along their actin track.

Oncology & Cancer

Scientists uncover novel mechanism of glioblastoma development

Most research on glioblastoma development, a complicated tumor of the brain with a poor prognosis, has focused on the gene transcription level, but scientists suggest that post-transcriptional regulation could be equally ...

Oncology & Cancer

Internal skin cancer prevention: Repairing UV damage in the skin

(Medical Xpress) -- Scientists at the Friedrich Miescher Institute for Biomedical Research (FMI) of the Novartis Research Foundation have elucidated the mechanisms underlying the repair of UV-induced damage in DNA, which ...

Medical research

MU scientist eyeing enzymes that could help fight flu

The influenza virus remains a worldwide threat to humans, causing an average of 36,000 deaths and 200,000 hospitalizations each year in the United States alone. As health care professionals prepare for another flu season, ...

Oncology & Cancer

Cancer's sweet tooth may be its weak link

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered that cancer cells tap into a natural recycling system to obtain the energy they need to keep dividing. In a study with potential implications ...

Diseases, Conditions, Syndromes

Vitamin B derivative helps diabetics with mild kidney disease

A vitamin B6 derivative may help slow or prevent the progression of mild kidney disease in patients with diabetes, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). ...

Oncology & Cancer

Antineoplastic agents associated with thyroid dysfunction

Antineoplastic agents such as immunotherapies and targeted therapies that specifically target signaling pathways in cancer cells are associated with thyroid dysfunction in 20%-50% of cancer patients taking them, which can ...

page 22 from 25